Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
410.69B | 421.67B | 370.68B | 417.62B | 462.82B | 302.38B | Gross Profit |
15.65B | 14.70B | 13.67B | 16.14B | 14.33B | 7.86B | EBIT |
11.09B | 10.17B | 9.48B | 12.23B | 10.63B | 5.00B | EBITDA |
7.80B | 9.51B | 4.23B | 8.15B | 8.74B | 4.69B | Net Income Common Stockholders |
6.06B | 5.59B | 2.10B | 4.91B | 6.38B | 3.45B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
15.22B | 5.80B | 20.86B | 7.49B | 6.71B | 3.20B | Total Assets |
160.56B | 113.97B | 130.21B | 107.18B | 116.99B | 119.89B | Total Debt |
45.87B | 14.05B | 29.66B | 20.56B | 9.50B | 14.60B | Net Debt |
40.02B | 8.25B | 21.15B | 13.07B | 2.79B | 11.40B | Total Liabilities |
110.66B | 64.35B | 84.70B | 62.98B | 77.63B | 87.09B | Stockholders Equity |
49.90B | 49.62B | 45.51B | 43.21B | 38.59B | 32.17B |
Cash Flow | Free Cash Flow | ||||
0.00 | 9.20B | 4.15B | -5.25B | 5.74B | -11.61B | Operating Cash Flow |
0.00 | 9.21B | 4.42B | -4.96B | 5.90B | -11.58B | Investing Cash Flow |
0.00 | -21.00M | 494.00M | -263.00M | -183.00M | -30.00M | Financing Cash Flow |
0.00 | -16.85B | 2.90B | 8.58B | -7.60B | 11.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥39.55B | 8.87 | 3.74% | 7.88% | 39.72% | ||
77 Outperform | ¥38.90B | 6.96 | 5.24% | 13.76% | 166.61% | ||
74 Outperform | ¥26.00B | 7.53 | 1.94% | 36.47% | 454.91% | ||
73 Outperform | ¥25.83B | 11.73 | 5.86% | 6.47% | -6.67% | ||
72 Outperform | ¥28.63B | 10.82 | 3.67% | -0.38% | 6.15% | ||
62 Neutral | $11.80B | 10.10 | -7.47% | 2.99% | 7.37% | -8.16% | |
57 Neutral | ¥34.28B | 498.77 | 5.90% | -46.16% | -98.31% |